Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 116
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00237198 | Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment | ||
| NCT05433207 | Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis | ||
| NCT02028884 | Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) | ||
| NCT00245414 | Trial of Pegasys® in Patients With Chronic Hepatitis C | ||
| NCT07239336 | Study of DONQ52 in Active Celiac Disease | ||
| NCT02514681 | A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer | ||
| NCT05494619 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS) | ||
| NCT00237211 | Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | ||
| NCT00779220 | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis | ||
| NCT05907980 | A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors | ||
| NCT05269667 | A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention | ||
| NCT00304551 | A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) | ||
| NCT06371417 | Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) | ||
| NCT02485483 | Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) Participants | ||
| NCT04432584 | A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors | ||
| NCT06589986 | A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis | ||
| NCT00661284 | A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.) | ||
| NCT00433849 | Clinical Study of R744 to Peritoneal Dialysis Patients | ||
| NCT01656525 | A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients | ||
| NCT05425446 | Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients | ||
| NCT00144560 | Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA) | ||
| NCT07107490 | A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER | ||
| NCT04732598 | A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer | ||
| NCT06723106 | Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) | ||
| NCT05012618 | A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion). | ||
| NCT02073279 | Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD) | ||
| NCT07416604 | A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A | ||
| NCT06793215 | A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer | ||
| NCT00433615 | Clinical Study of R744 to Predialysis Patients | ||
| NCT02847637 | A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors | ||
| NCT02795767 | A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors | ||
| NCT00144508 | Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA) | ||
| NCT04708847 | A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer | ||
| NCT02539680 | Intestinal Phosphate Transporter Expression in CKD Patients | ||
| NCT05503264 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis | ||
| NCT02431117 | Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30 | ||
| NCT05679570 | Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial) | ||
| NCT01989780 | Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer | ||
| NCT00144599 | Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) | ||
| NCT01817699 | Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients | ||
| NCT00144547 | Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP | ||
| NCT01041404 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | ||
| NCT00144625 | Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) | ||
| NCT00144573 | Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment | ||
| NCT00144482 | A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy | ||
| NCT05686369 | A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study) | ||
| NCT02748837 | A Study of ERY974 in Patient With Advanced Solid Tumors | ||
| NCT00210249 | Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment | ||
| NCT02622321 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors | ||
| NCT00467012 | Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer |
